Li Chen

8PUBLICATIONS

143CO-AUTHORS

Molecular targetsHaematological tumoursSoftware quality, processes and metricsMedical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 17, 2026

Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

|Mar 17, 2026

Dynamic switching of apoptosis-modulating BIM heterodimers in response to BH3 mimetics in xenograft models of hematologic malignancies.

Jeevan Prasaad Govindharajulu, Sharon Fluss, Melinda G Hollingshead

|Feb 19, 2026

Endosialin (CD248) Cancer Role and Therapeutics: 33 Years on.

Beverly A Teicher, Li Chen, Dianne L Newton

|Nov 06, 2025

Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.

Cloud P Paweletz, Thomas D Forbes, Laura Yee

|Oct 09, 2025

Phase II Study of Vismodegib in Patients With <i>SMO-</i> or <i>PTCH1</i>-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Anne S Tsao, Zihe Song, Alan L Ho

|Feb 11, 2025

Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors.

Amy L Funk, Meghri Katerji, Marwa Afifi

Pageof 2

Frequent Collaborators

Stanley R Hamilton

David R Patton

James H Doroshow

Peter J O'Dwyer

Melinda G Hollingshead

Jacob Gross

Latifa Jackson

Yvonne A Evrard

Donna Brunnquell

Shahanawaz Jiwani

Frequent Collaborators

Stanley R Hamilton

David R Patton

James H Doroshow

Peter J O'Dwyer